Join the New Wave of Ultrasound Technology
Use of MRI for the routine diagnosis of musculoskeletal
conditions in the U.S. will cost $2.5 billion by 2020.
Echometrix’s advancement of
ultrasound technology for the evaluation
of musculoskeletal conditions will help to
solve this problem by making ultrasound
easier to use by the treating clinician.
Workers, soldiers and athletes will all
benefit from a more available and more
objective evaluation at initial diagnosis
and during rehabilitation
Our opportunity is well timed because ultrasound equipment miniaturization, cost reduction and improvements in image quality have dramatically expanded the useful applications for ultrasound in healthcare. One of the least penetrated markets for ultrasound is musculoskeletal, and major players in the ultrasound industry are very focused on this market.
Echometrix is a Wisconsin Qualified New Business Venture - qualified and in-state investors receive a 25% tax credit from the State of Wisconsin.
If you are interested in an investment opportunity with Echometrix,
contact Echometrix at email@example.com or call 608.217.2685